F. Rivolta
, A. Chiei Gallo
, A. Sangalli
, V. Pravettoni
1UOC General Medicine Immunology and Allergology, IRCCS Ca' Granda Foundation, Ospedale Maggiore Policlinico, Milan, Italy
2Allergy and Clinical Immunology Residency, University of Milan, Milan, Italy
HistoryPublished: 13 December 2022
Accepted: 05 December 2022
Received: 04 October 2022
The use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.
Acetylsalicylic acid; aspirin; aspirin desensitization; desensitization; NSAIDs; hypersensitivity drug reactions; ASA adverse reaction; NSAID hypersensitivity; coronary artery disease; pregnancy.